MedPath

Busulfan

These highlights do not include all the information needed to use BUSULFAN INJECTION safely and effectively. See full prescribing information for BUSULFAN INJECTION. BUSULFAN Injection, for intravenous use Initial U.S. Approval: 1999

Approved
Approval ID

fe0ddd44-ef02-4827-b164-7fcbb45bcc1b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 5, 2024

Manufacturers
FDA

Accord Healthcare, Inc

DUNS: 604222237

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

busulfan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16729-351
Application NumberANDA210148
Product Classification
M
Marketing Category
C73584
G
Generic Name
busulfan
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 5, 2024
FDA Product Classification

INGREDIENTS (3)

BUSULFANActive
Quantity: 6 mg in 1 mL
Code: G1LN9045DK
Classification: ACTIB
N,N-DIMETHYLACETAMIDEInactive
Code: JCV5VDB3HY
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Busulfan - FDA Drug Approval Details